POST LEONARD E sold 5K shares of CG ONCOLOGY, INC. on the open market
Open‑market sale worth $200.5K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/1/2025ACC: 0001193125-25-226964
-5K
Net shares
Net seller
$200.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5K acquired · 10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5K
Price / share
$0.60
Trade value
$3K
% of position
New position
9/30/2025
0.00→5K
Common Stock
Direct
Shares
−5K
Price / share
$40.09
Trade value
$200.45K
% of position
New position
9/30/2025
5K→0.00
Total
Net shares
+0.00
Net value
-$197.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/30/2025 | M · Option Exercise | +5K | $0.60 | $3K | New position | 0.00 | 5K |
| Common Stock Direct | 9/30/2025 | S · Sale | −5K | $40.09 | $200.45K | New position | 5K | 0.00 |
| Total | +0.00 | -$197.45K | ||||||
Derivative Transactions1
Director Stock Option (right to buy)
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
0.6
Held after
119.08K
Exercisable
—
9/30/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy) Direct | Common Stock5K shares | 9/30/2025 | M · Option Exercise | −5K | 0.6 | — | 119.08K |